Remove 2002 Remove Intellectual Property Law Remove Inventor Remove Patent
article thumbnail

Intersection of Intellectual Property Law and Competition Law with respect to Cross Licensing Agreements

IIPRD

This has led to the introduction of intellectual property rights which are a set of exclusionary rights as it excludes the world from enjoying a set of rights arising out an invention or creation, except the inventor or creator.

article thumbnail

Innovating the Term ‘Inventor’: AI and Patent Law

IPilogue

Recently, AI technology once again exceeded the legal community’s expectations by filing a patent for its invention of interlocking food containers. Under patent law, it is the general expectation that inventors are humans, not robots. Patent Law in Canada. 2002 SCC 77 (“Apotex”).

Inventor 106
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Amgen Inc. v. Sandoz Inc, No. 2022-1147 (Fed. Cir. Apr. 19, 2023)

Intellectual Property Law Blog

This case is an appellate review of the district court’s findings regarding patent obviousness and priority date. Amgen also owns three patents — the ’638, ’101, and ’541 patents — covering Otezla. Issues Is the ’638 patent invalid as obvious given objective indicia of non-obviousness? Both Amgen and Sandoz appealed.

Art 130
article thumbnail

Australia’s Reversal of its DABUS decision on AI-Generated Inventions: How Does this Impact an Imminent Canadian Discussion on AI Inventorship?

IPilogue

Reversing what seemed like a victory for supporters of AI-owned intellectual property, the full bench of the Federal Court of Australia has confirmed the majority view of the world: only human inventors can own patent rights to their creations. What Does This Mean in the Canadian Context?

Invention 111
article thumbnail

Evergreening of Patents

Kashishipr

The evergreening of patents is a common element of pharmaceutical patents. The evergreening of patents is a common element of pharmaceutical patents. The most crucial method that global medicine enterprises use is drug evergreening of patents.

Patent 105
article thumbnail

Conference Posters and Materials: Beware! They Can Constitute Prior Art

Canadian Intellectual Property Blog

Unfortunately, what is good for the sharing of information is often not good for the patenting of inventions that arise from the research and products presented at these conferences. 2020 FC 621 , a poster was presented at a conference in Baltimore in 2002, 18 years previous. In Biogen Canada Inc. Taro Pharmaceuticals Inc.

Art 52
article thumbnail

Defining Boundaries: IP Law Addresses Exterritoriality, Lexicography & Human Touch

LexBlog IP

.” But our problem often is that the law, or lawyers, frequently use unfamiliar or exotic terms that others claim have no more understood meaning than a reference to a “ vermicious kind ,” and those or other lawyers may overuse a word that they do not seem to actually comprehend. Eset, LLC, a patent case.

Law 52